Sameer Sabir

Sameer Sabir has extensive work experience in various positions. Sameer is the Co-Founder and CEO of Brixton Biosciences since October 2019. Prior to that, they worked as the President of the SevenOaks Division at Medline Industries, Inc. from April 2017 to July 2018. Sameer also served as the CEO of SevenOaks Biosystems from July 2014 to March 2017. Sameer held the position of General Manager - Cellutome at Kinetic Concepts from November 2012 to August 2013. Before that, Sameer was the CEO of MoMelan Technologies from January 2010 to November 2012. Sameer also worked as the Director at Cinnabar Consulting from January 2003 to August 2006. Sameer gained initial experience as an Executive at Commerzbank Securities from January 2002 to January 2003 and as an Analyst at JP Morgan from July 2000 to January 2002.

Sameer Sabir has a Bachelor of Science degree in Immunology from the University of London, which they obtained from 1997 to 2000. Sameer then pursued a Master's degree in Business Administration with a focus on Biotechnology and Business from the MIT Sloan School of Management from 2006 to 2008. Finally, Sameer completed a Master of Science degree in Health Sciences & Technology/Entrepreneurship from the Harvard-MIT Division of Health Sciences & Technology during the academic year 2008-2009.